目的 探讨基于护士驱动的多学科协作(multi-disciplinary team,MDT)护理模式对儿童特应性皮炎(atopic dermatitis,AD)患儿疾病严重程度、生活质量及家长满意度的影响。方法 选取2023年3月—2025年1月于新疆医科大学第一附属医院就诊的102例AD患儿为研究对象,随机分为对照组(n=51)和观察组(n=51)。对照组实施常规护理;观察组在此基础上实施护士驱动下的MDT护理模式。采用特应性皮炎评分指数(severity scoring of atopic dermatitis,SCORAD)、湿疹面积及严重程度指数(eczema area and severity index,EASI)、儿童皮肤病生活质量指数(children's dermatology life quality index,CDLQI)及家长满意度等评估干预效果。结果 干预后,观察组SCORAD总评分、EASI总评分及CDLQI评分均低于对照组,差异具有统计学意义(P<0.05);观察组家长满意度达86.27%,高于对照组的56.86%,差异具有统计学意义(P<0.05)。结论 护士驱动的MDT护理模式可有效缓解AD患儿临床症状,改善生活质量,提升家长满意度,为AD患儿的全程化管理提供了系统化、可推广的实践路径。
Abstract
Objective To investigate the effects of a nurse-led multidisciplinary team (MDT) care model on severity of disease, quality of life, and parental satisfaction in children with atopic dermatitis (AD). Methods From March 2023 to January 2025, 102 children with AD who were treated in The First Affiliated Hospital of Xinjiang Medical University were recruited as research participants and randomly assigned to either a control group (n=51) or an observation group (n=51). The control group received routine care; the observation group implemented the MDT nursing model led by nurses. The SCORAD index, EASI index, CDLQI index, and parental satisfaction were used to evaluate the effect. Results After the nursing intervention, the observation group demonstrated significantly reduced SCORAD, EASI, and CDLQI scores compared to the control group, with statistically significant differences (P<0.05) observed across all metrics; the parental satisfaction of the observation group reached 86.27%, significantly higher than 56.86% of the control group (P<0.05). Conclusion The nurse-led MDT care model can effectively alleviate the clinical symptoms of children with AD, improve quality of life, and enhance parental satisfaction, and provide a systematic and popularized practice path for the whole process management of AD.
关键词
护士驱动 /
多学科协作 /
儿童 /
特应性皮炎 /
护理干预
Key words
nurse-led /
multidisciplinary collaboration /
children /
atopic dermatitis /
nursing intervention
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] STÄNDER S. Atopic dermatitis[J]. N Engl J Med, 2021, 384(12): 1136-1143.
[2] KELLOGG C, SMOGORZEWSKI J.Update on atopic dermatitis[J]. Adv Pediatr, 2023, 70(1): 157-170.
[3] 王芳芳, 于朋, 劳成军. 益生菌在儿童特应性皮炎防治中的研究进展[J]. 国际免疫学杂志, 2024, 47(5): 572-576.
[4] ALI F, VYAS J, FINLAY AY. Counting the burden: atopic dermatitis and healthrelated quality of life[J]. Acta Derm Venereol, 2020, 100(12): adv00161.
[5] ZHOU X, WEI T.Application of multi-disciplinary team nursing model enhances recovery after surgery for total hip arthroplasty and total knee arthroplasty[J]. Am J Transl Res, 2024, 16(8): 3938-3949.
[6] WEI J, FANG X, QIAO J, et al.Construction on teaching quality evaluation indicator system of multidisciplinary team clinical nursing practice in China: a Delphi study[J]. Nurse Educ Pract, 2022, 64: 103452.
[7] FITZGERALD MC, NOONAN M, LIM E, et al.Multi-disciplinary, simulation-based, standar-dised trauma team training within the victorian state trauma system[J]. Emerg Med Australas, 2023, 35(1): 62-68.
[8] SOON JJY, JUAN DWK, ONG WS, et al.Implementation of a multi-disciplinaryteam and quality of goals of care discussions in palliative surgical oncology patients[J]. Ann Surg Oncol, 2023, 30(13): 8054-8060.
[9] ONG HL, SOKOLOVA I, AGUR W.Impact of regional multi-disciplinary team on the management of complex urogynaecology conditions[J]. Int Urogynecol J, 2023, 34(9): 2163-2169.
[10] KUNZ B, ORANJE AP, LABRÈZE L, et al. Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis[J]. Dermatology, 1997, 195(1): 10-19.
[11] SINGLETON H, HODDER A, ALMILAJI O, et al. Educational and psychological interventions for managing atopic dermatitis[J]. Cochrane Database Syst Rev, 2024, 8(8): CD014932.
[12] 中华医学会皮肤性病学分会免疫学组, 特应性皮炎协作研究中心. 中国特应性皮炎诊疗指南 (2020版)[J]. 中华皮肤科杂志, 2020, 53(2): 81-88.
[13] 李钦峰. 儿童特应性皮炎规范治疗与长期管理[J]. 中国实用儿科杂志, 2021, 36(9): 645-648.
[14] YOUNG TK, GLICK AF, YIN HS, et al.Management of pediatric atopic dermatitis by primary care providers: a systematic review[J]. Acad Pediatr, 2021, 21(8): 1318-1327.
[15] NARLA S, SILVERBERG JI.Dermatology for the internist: optimal diagnosis and management of atopic dermatitis[J]. Ann Med, 2021, 53(1): 2165-2177.
[16] NAPOLITANO M, FABBROCINI G, MARTORA F, et al.Children atopic dermatitis: diagnosis, mimics, overlaps, and therapeutic implication[J]. Dermatol Ther, 2022, 35(12): e15901.
[17] HANIFIN JM, BAGHOOMIAN W, GRINICH E, et al.The eczema area and severity index-a practical guide[J]. Dermatitis, 2022, 33(3): 187-192.
[18] TAWFIK SS, THOMAS BR, KELSELL DP, et al.Dermatology quality of lifeindex scores in Bangladeshi patients with atopic eczema and their families in East London[J]. Br J Dermatol, 2023, 188(4): 524-532.
[19] GÜREL Dİ, SOYER Ö, ŞAHINER ÜM. Systemic treatments in atopic dermatitis in children[J]. Turk J Pediatr, 2023, 65(6): 887-905.
[20] 刘艳, 田晶, 梁源, 等. 儿童特应性皮炎的新药治疗进展[J]. 中国新药杂志, 2023, 32(19): 1959-1965.
[21] WANG Q, LIU L, GAO S, et al.Guidelines for the management of atopic dermatitis in children: a systematic review[J]. Int Arch Allergy Immunol, 2023, 184(2): 132-141.
[22] THYSSEN JP, BIEBER T, KLEYN CE, et al.Baricitinib provides rapid and sustained improvements in absolute EASI and SCORAD outcomes in adults with moderate-to-severe atopic dermatitis[J]. J Dermatolog Treat, 2023, 34(1): 2216322.
[23] 杨帆, 李冬冬, 王小勤, 等. 儿童特应性皮炎居家皮肤护理方式与疾病严重程度的关系[J]. 医学新知, 2024, 34(5): 497-507.
[24] WANG M, SUN Y, ZHANG M, et al.Effects of high-quality nursing care on quality of life, survival, and recurrence in patients with advanced nonsmall cell lung cancer[J]. Medicine, 2022, 101(37): e30569.
[25] KHAN A, ADALSTEINSSON J, WHITAKER-WORTH DL.Atopic dermatitis and nutrition[J]. Clin Dermatol, 2022, 40(2): 135-144.
[26] MOSTAFA N, SMITH SD.Improving psychological health outcomes in children with atopic dermatitis[J]. Clin Cosmet Investig Dermatol, 2023, 16: 2821-2827.
基金
湖北陈孝平科技发展基金会2024年度免疫性疾病研究槐杞黄专项基金“槐杞黄颗粒联合标准化治疗对儿童支气管哮喘合并特应性皮炎的临床疗效研究”(CXPJJH124010-042); “天山英才”医药卫生高层次人才培养计划“基于生物标志物的哮喘精准分型、分期和治疗策略研究”(TSYC202301B003)